SYNLOGIC, INC.
Uses synthetic biology to engineer oral living medicines for rare metabolic disorders.
SYBX | US
Overview
Corporate Details
- ISIN(s):
- US87166L1008
- LEI:
- Country:
- United States of America
- Address:
- PO BOX 30, 1890 WINCHESTER
- Website:
- https://www.synlogictx.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Synlogic, Inc. is a clinical-stage biopharmaceutical company that pioneers the application of synthetic biology to develop a novel class of living medicines called Synthetic Biotics™. The company engineers therapeutic microbes designed to perform specific metabolic functions within the gastrointestinal tract to treat disease. Synlogic's pipeline is primarily focused on developing oral, non-systemically absorbed biotherapeutics for rare metabolic disorders, with a lead program targeting Phenylketonuria (PKU). By working at the intersection of biology and engineering, the company aims to create transformative new treatments for patients with serious diseases and limited options.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all SYNLOGIC, INC. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for SYNLOGIC, INC.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for SYNLOGIC, INC. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
